You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤雙鶴(600062.SH):擬31.15億元收購華潤紫竹100%股權 進一步豐富公司專科領域產品線
格隆匯 02-23 17:41

格隆匯2月23日丨華潤雙鶴(600062.SH)公佈,為落實公司十四五戰略規劃,進一步豐富公司專科領域產品線,完善產品矩陣,形成“女性健康+兒科”專科產品序列,提升品牌影響力,增強公司盈利能力、綜合競爭力,公司擬與北藥集團簽署《關於華潤紫竹藥業有限公司之股權轉讓協議》,收購北藥集團持有的華潤紫竹100%股權。

本次交易作價以評估值為依據,評估基準日為2023年8月31日,最終採用收益法評估結果作為評估結論,確認華潤紫竹股東全部權益價值評估值311,545.31萬元。以資產評估報吿確認的華潤紫竹股東全部權益價值評估值為依據,華潤紫竹100%股權轉讓價款為人民幣311,545.31萬元,較其單體財務報表淨資產賬面價值115,214.58萬元增值率為170.40%。本次交易的資金來源為公司自有或自籌資金。

華潤紫竹主要從事女性健康用藥及器械、口腔用藥、眼科用藥、糖尿病用藥、原料藥研發生產銷售業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account